Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Neuroendocrine Tumors 14Carcinoid Tumor 5Gastro-enteropancreatic neuroendocrine tumor 4Acromegaly 4Serotonin Syndrome 2Pituitary Neoplasms 2Neoplasm Metastasis 2Carcinoma, Hepatocellular 2Prostatic Neoplasms 1Pheochromocytoma 1Peritoneal Neoplasms 1Paraganglioma 1Pancreatic Neoplasms 1Neuroendocrine Tumour With Carcinoid Symptoms 1Neuroendocrine Tumors in Lung 1Neoplastic Cells, Circulating 1Neoplasms 1Intestinal Obstruction 1Growth Hormone-Secreting Pituitary Adenoma 1Gigantism 1Gastrointestinal Neoplasms 1Flushing 1Endocrine Tumors 1Diarrhea 1Carcinoma, Merkel Cell 1Carcinoma 1Carcinoid Heart Disease 1Adenoma, Islet Cell 1

Interventions

pasireotide 2lanreotide 1Tissue Banks 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gigantism × lanreotide × Clear all
NCT01861717 2021-09-30

A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.

Saint John's Cancer Institute

Phase 4 Terminated
4 enrolled 5 charts
Endocrine

Acromegaly, Gigantism, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡